Joar Guterstam
- Institutionen för klinisk neurovetenskap
- Centrum för psykiatriforskning vid CNS
- Behandling av skadligt bruk och beroende – Johan Francks forskargrupp
Om mig
Leg läkare, specialist i psykiatri och beroendemedicin.
Docent i psykiatri.Ordförande i Svensk förening för beroendemedicin (https://svenskberoendemedicin.se).
Styrelseledamot och sekreterare i European Federation of Addiction Societies (https://www.eufas.net).
Forskningsbeskrivning
Min doktorsavhandling (2017) handlade om hur hjärnans opioidsystem är involverat i amfetaminberoende, vilket undersöktes med hjärnavbildningsteknikerna PET och fMRI. Idag arbetar jag med framför allt med projekt som berör farmakologisk behandling av beroendetillstånd, och biomarkörer inom beroendemedicin.
Undervisning
Jag föreläser regelbundet inom psykiatri, beroendemedicin och psykofarmakologi. Jag är ansvarig för flera kurser riktade till ST-läkare inom beroendemedicin, och kursen i biologisk psykiatri för doktorander inom forskarskolan i klinisk psykiatri.
Jag har också bidragit till flera läroböcker och skrivit andra typer av texter för undervisning.
Artiklar
- Journal article: LANCET REGIONAL HEALTH-EUROPE. 2025;54:101310Soderpalm B; Lido H; Franck J; Hakansson A; Lindqvist D; Heilig M; Guterstam J; Samuelson M; Askerup B; Wallmark-Nilsson C; de Bejczya A
- Article: PHARMACOLOGICAL REPORTS. 2025;77(3):840-849Hong M-G; Khemiri L; Guterstam J; Franck J; Jayaram-Lindstrom N; Melas PA
- Article: ALCOHOL AND ALCOHOLISM. 2024;59(6):agae070Hammarberg A; Hammarberg SI; Cuellar SR; Guterstam J
- Article: PSYCHIATRY RESEARCH-NEUROIMAGING. 2024;343:111860Kaboodvand N; Shabanpour M; Guterstam J
- Article: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2024;243:116075Guterstam J; Tavic C; Barosso M; Beck O
- Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2024;1240:124142Sinapour H; Guterstam J; Grosse S; Astorga-Wells J; Stambeck P; Stambeck M; Winberg J; Hermansson S; Beck O
- Article: PSYCHOLOGICAL MEDICINE. 2024;54(7):1391-1402Mansson V; Pettersson E; Mittendorfer-Rutz E; Guterstam J; Berman AH; Jayaram-Lindstroem N; Molero Y
- Article: LAKARTIDNINGEN. 2024;121:23157Guterstam J; Heilig M
- Journal article: NEUROSCIENCE APPLIED. 2024;3:104490Guterstam J; Hammarberg SI; Cuellar SR; Hammarberg A
- Article: EUROPEAN ADDICTION RESEARCH. 2024;30(1):1-13Brynte C; Konstenius M; Khemiri L; Backer A; Guterstam J; Levin FR; Jayaram-Lindstrom N; Franck J
- Journal article: EUROPEAN ADDICTION RESEARCH. 2024;30(3):138-139Guterstam J
- Article: BMC PUBLIC HEALTH. 2023;23(1):1608Metrebian N; Carter B; Eide D; Mcdonald R; Neale J; Parkin S; Dascal T; Mackie C; Day E; Guterstam J; Horsburgh K; Kaberg M; Kelleher M; Smith J; Thiesen H; Strang J
- Article: LAKARTIDNINGEN. 2022;119Guterstam J
- Article: EUROPEAN ADDICTION RESEARCH. 2022;28(3):210-219Guterstam J; Jayaram-Lindstrom N; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
- Article: BMC PSYCHIATRY. 2021;21(1):458Khemiri L; Brynte C; Konstenius M; Guterstam J; Rosendahl I; Franck J; Jayaram-Lindstrom N
- Article: LAKARTIDNINGEN. 2020;117:20165Guterstam J
- Article: MOLECULAR PAIN. 2020;16:1744806920927625Ponten M; Fust J; Kosek E; Guterstam J; Jensen K
- Article: PSYCHOPHARMACOLOGY. 2020;237(1):69-82Khemiri L; Steensland P; Guterstam J; de Manzano O; Franck J; Jayaram-Lindstrom N
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:s177Guterstam J; Jayaram-Lindstrom N; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
- Article: DRUG AND ALCOHOL DEPENDENCE. 2018;191:91-97Guterstam J; Jayaram-Lindstrom N; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:s1064-s1065Guterstam J; Lindström NJ; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
- Article: TRANSLATIONAL PSYCHIATRY. 2017;7(4):e1104Jayaram-Lindstrom N; Guterstam J; Haggkvist J; Ericson M; Malmlof T; Schilstrom B; Halldin C; Cervenka S; Saijo T; Nordstrom A-L; Franck J
- Article: LAKARTIDNINGEN. 2016;113:DSU6Bloniecki Kallio V; Guterstam J; Franck J
- Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015;25(12):2240-2251Khemiri L; Steensland P; Guterstam J; Beck O; Carlsson A; Franck J; Jayaram-Lindstrom N
- Article: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2015;39(11):2200-2208Walther L; de Bejczy A; Lof E; Hansson T; Andersson A; Guterstam J; Hammarberg A; Asanovska G; Franck J; Soderpalm B; Isaksson A
- Article: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2015;39(11):2189-2199de Bejczy A; Lof E; Walther L; Guterstam J; Hammarberg A; Asanovska G; Franck J; Isaksson A; Soderpalm B
- Journal article: LAKARTIDNINGEN. 2015;112:DEEXGuterstam J; Hammarberg A; Finn SW; Cervenka S; Lekander M; Petrovic P; Hedman E
- Article: ADDICTION. 2014;109(3):440-449Konstenius M; Jayaram-Lindstroem N; Guterstam J; Beck O; Philips B; Franck J
- Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2013;16(4):763-769Guterstam J; Jayaram-Lindstrom N; Cervenka S; Frost JJ; Farde L; Halldin C; Franck J
- Journal article: LAKARTIDNINGEN. 2013;110(3):101Guterstam J
- Journal article: EUROPEAN PSYCHIATRY. 2013;28(S1):1Konstenius M; Jayaram-Lindström N; Guterstam J; Philips B; Beck O; Franck J
- Article: BMC PSYCHIATRY. 2012;12:221Bramness JG; Gundersen OH; Guterstam J; Rognli EB; Konstenius M; Loberg E-M; Medhus S; Tanum L; Franck J
- Article: PLOS ONE. 2012;7(6):e39882Khemiri L; Guterstam J; Franck J; Jayaram-Lindstrom N
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2012;22:s55Guterstam J; Jayaram-Lindstrom N; Cervenka S; Halldin C; Farde L; Frost J; Franck J
- Journal article: LAKARTIDNINGEN. 2006;103(15-16):1225Guterstam J; Sjöstrand M
- Visa fler
Alla övriga publikationer
- Preprint: MEDRXIV. 2024Hong M-G; Khemiri L; Guterstam J; Franck J; Jayaram-Lindström N; Melas PA
- Review: LAKARTIDNINGEN. 2022;119:21105Johansson Capusan A; Guterstam J; Ginsberg Y; Borg Skoglund L
- Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S1054Khemiri L; Steensland P; Guterstam J; Carlsson A; Franck J; Jayaram-Lindstrom N
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S1065-S1066Guterstam J; Lindstrom NJ; Berrebi J; Petrovic P; Ingvar M; Fransson P; Franck J
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S691-S692Guterstam J; Jayaram-Lindstrom N; Berrebi J; Ingvar M; Franck J
- Corrigendum: ADDICTION. 2014;109(9):1571-1572Konstenius M; Jayaram-Lindstroem N; Guterstam J; Beck O; Philips B; Franck J
- Conference publication: EUROPEAN PSYCHIATRY. 2014;28:e109Konstenius M; Jayaram-Lindstrom N; Guterstam J; Philips B; Beck O; Franck J
- Conference publication: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2014;38:306AJayaram-Lindstrom N; Khemiri L; Carlsson A; Guterstam J; Steensland P; Franck J
- Conference publication: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2014;38:158AKhemiri L; Steensland P; Guterstam J; Carlsson A; Jayaram-Lindstrom N; Franck J
- Conference publication: BIOLOGICAL PSYCHIATRY. 2014;75(9):379SJayaram-Lindstrom N; Haggkvist J; Guterstam J; Malmlof T; Halldin C; Schilstrom B; Nordstrom A-L; Franck J
- Conference publication: BIOLOGICAL PSYCHIATRY. 2014;75(9):18SKhemiri L; Steensland P; Guterstam J; Carlsson A; Jayaram-Lindstrom N; Franck J
- Conference publication: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2012;36:64ASoderpalm B; deBejczy A; Ericson M; Guterstam J; Hammarberg A; Franck J; Asanovska G; Lof E
- Conference publication: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2012;15:41Franck J; Konstenius M; Jayaram-Lindstrom N; Philips B; Guterstam J
- Conference publication: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 2012;36:358ALof E; deBejczy A; Guterstam J; Hammarberg A; Franck J; Asanovska G; Soderpalm B
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2012;22:S55Guterstam J; Jayaram-Lindstrom N; Cervenka S; Halldin C; Farde L; Frost J; Franck J
Forskningsbidrag
- Swedish Research Council1 January 2024 - 31 December 2027Internet-delivered cognitive behavior therapy (CBT) for social anxiety disorder is an evidence-based treatment in regular health care. Still, a considerable proportion of treated patients do not respond. There is also a debate on the importance of patients expectations’ for therapeutic outcomes. However, experimental evidence is lacking to answer this question. Our aim is thus to investigate the placebo response in social anxiety disorder, and the link between initial placebo responsiveness and subsequent outcome of CBT. First, we will manipulate expectations of anxiety relief. A benzodiazepine (a common anti-anxiety drug) will be administered with correct or incorrect information about clinical efficacy during a public speaking task. Self-reports and moment-to-moment variability in neural response will be measured with functional magnetic resonance imaging (fMRI) during the manipulation of expectations. The balanced placebo design allows us to dissect the total treatment effect into its components: drug, placebo, and interactions between the two. Second, patients undergo internet-delivered CBT after completing the placebo experiments. This project aims to unravel expectations´ influence on treatment response, and has a two-fold significance, 1) the scientific understanding of the neural mechanisms of treatment expectations, central for placebo, and 2) the development of pre-treatment predictors of CBT outcome which could improve precision in clinical decision making.
- Swedish Research Council for Health Working Life and Welfare1 January 2021 - 31 December 2023
- Swedish Research Council1 January 2013 - 31 December 2015
- Swedish Research Council1 January 2010 - 31 December 2012
Anställningar
- Anknuten till Forskning, Klinisk neurovetenskap, Karolinska Institutet, 2024-2026
Examina och utbildning
- Docent, Psykiatri, Karolinska Institutet, 2024
- Medicine Doktorsexamen, Karolinska Institutet, 2017
- Läkarexamen, Karolinska Institutet, 2006
Gästforskning och resestipendier
- Post-doctoral research, Zentralinstitut für Seelische Gesundheit, 2019-2020